Topical anti-infectives and mucosal vaccines developer NanoBio (see the April 28, 2008 LRNJ) recently signed an exclusive licensing agreement with GlaxoSmithKline (GSK) for a 150 nm to 400 nm oil-in-water emulsion-based, over-the-counter (OTC),...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)
+65 6592-6978